Medically reviewed by Dr. Diala Alatassi.
If you've searched "oral Zepbound," you've probably landed on a mix of confusing and even misleading information. Here's the direct answer: there is no FDA-approved oral tirzepatide (Zepbound) pill. Zepbound is only available as a weekly injection. Any product marketed online as an "oral Zepbound" or "tirzepatide pill" is not an approved medication and should be treated with caution.
The good news is that a real, FDA-approved oral GLP-1 option does exist: Foundayo (orforglipron). It works differently from tirzepatide, but it delivers the same core benefit patients are searching for — appetite control in pill form, no injections required.
This guide explains the difference between Zepbound and Foundayo, what's actually approved and available today, and how Phoenix residents can get a personalized recommendation through a video visit with TeleSlim Clinic. We'll also cover where these options fit alongside other proven treatments, from semaglutide to injectable tirzepatide, so you can have an informed conversation with your provider.
Why There's No Oral Zepbound (Yet)
Zepbound is the brand name for tirzepatide, a medication that activates both the GLP-1 and GIP hormone receptors to slow digestion, reduce appetite, and improve insulin response. It was FDA-approved for weight management in 2023 and for obstructive sleep apnea in 2024 — but only as a once-weekly injection.
Tirzepatide is a large peptide molecule, and peptides break down in the digestive system before they can be absorbed. That's the core reason an oral tirzepatide tablet doesn't exist yet: the science of getting a peptide this size to survive digestion and reach the bloodstream in pill form is still unresolved. Manufacturers are actively researching oral delivery methods, but as of today, no oral tirzepatide product has FDA approval.
If you come across a pill, capsule, drop, or dissolvable tablet sold online as "oral tirzepatide" or "oral Zepbound," it is not an FDA-approved medication. These products are typically compounded or unregulated, and they don't carry the same safety and efficacy backing as the approved injectable. TeleSlim Clinic does not prescribe compounded medications of any kind.
Foundayo (Orforglipron): The Oral GLP-1 That Is Actually Approved
Foundayo is the brand name for orforglipron, an FDA-approved oral GLP-1 receptor agonist. Unlike tirzepatide, orforglipron was designed from the start to survive digestion and work as a once-daily pill — which is exactly why it reached approval while an oral tirzepatide hasn't.
Foundayo activates the GLP-1 receptor to slow stomach emptying and increase feelings of fullness, helping reduce overall calorie intake. Because it targets one receptor rather than two, some patients find its side-effect profile a bit gentler than dual-target injectables, though individual response varies. The most common effects are mild nausea, headache, or fatigue, especially during the first few weeks, and they typically ease as your body adjusts.
Results build gradually. Most patients notice reduced hunger within the first few weeks, with more meaningful weight loss over three to six months of consistent use combined with dietary changes. Foundayo doesn't require refrigeration or injection supplies, which many patients find more convenient for daily life and travel — the exact appeal that draws people to search for "oral Zepbound" in the first place.
Foundayo isn't a stand-alone fix. It works best alongside the nutrition and lifestyle coaching your TeleSlim provider builds into your treatment plan.
Accessing Foundayo and Other GLP-1 Medications in Phoenix Through Telehealth
Arizona has some of the more telehealth-friendly regulations in the country, which means Phoenix patients don't need to drive to a clinic to start treatment. Arizona law allows licensed physicians to prescribe medication after a live video visit, as long as the standard of care matches an in-person exam — exactly how TeleSlim Clinic operates.
Here's what that looks like in practice: you complete an online intake, meet with a TeleSlim provider by video from anywhere in the Phoenix metro — including Scottsdale, Tempe, Mesa, Chandler, or Glendale — and if a GLP-1 medication like Foundayo or injectable tirzepatide is appropriate for you, your prescription is sent electronically to the pharmacy of your choice near your home or workplace. TeleSlim does not dispense compounded medications and does not require in-person visits at any point in your care.
Because Arizona's larger pharmacy chains have seen high demand for GLP-1 medications, your TeleSlim provider can help you understand current availability and, when needed, discuss alternative options so a supply gap doesn't stall your progress.
Other Weight Loss Medications TeleSlim Offers
Foundayo is one of several evidence-based options available through TeleSlim Clinic. Depending on your health history, goals, and insurance coverage, your provider might also discuss:
- Semaglutide (Wegovy, Ozempic) — the original GLP-1 medication that popularized this treatment category
- Tirzepatide (injectable Zepbound, Mounjaro) — dual GLP-1/GIP action in weekly injection form, the FDA-approved way to access tirzepatide today
- Liraglutide (Saxenda) — a daily injectable GLP-1 option
- Phentermine and phentermine-topiramate (Qsymia) — appetite-suppressing options for patients who aren't candidates for GLP-1 therapy
- Naltrexone-bupropion (Contrave) — a non-GLP-1 option that targets appetite and cravings through different pathways
You can see the full range of medications TeleSlim prescribes, along with how each one works, on the TeleSlim Clinic Phoenix weight loss medications page. Your provider will help match you to the option that's actually approved and fits your health profile, rather than chasing a product that doesn't exist yet.
What to Expect at Your First Visit
Your first TeleSlim video visit typically runs 20 to 30 minutes. Your provider will review your medical history, current medications, and weight-related health concerns such as prediabetes, high blood pressure, or sleep apnea. From there, they'll recommend a medication and starting dose — whether that's Foundayo, injectable tirzepatide, or another option — explain what side effects to watch for, and set a follow-up schedule to track your progress and adjust your plan as needed.
Most Phoenix patients hear back from their pharmacy within a day or two of their visit, and ongoing check-ins happen by video or secure messaging, so you're never left guessing about next steps.
Frequently Asked Questions
Is oral Zepbound available in Phoenix? No. There is no FDA-approved oral tirzepatide product anywhere in the U.S., including Phoenix. Zepbound is only available as an injection. If you're looking for a pill, Foundayo (orforglipron) is the FDA-approved oral GLP-1 option your TeleSlim provider can discuss.
Is Foundayo the same as Zepbound in pill form? No. Foundayo contains a different active ingredient (orforglipron) that targets only the GLP-1 receptor, while Zepbound (tirzepatide) targets both GLP-1 and GIP. They work similarly but aren't interchangeable, and your provider can explain which fits your goals.
Can I switch between an injectable GLP-1 and an oral one like Foundayo? Often, yes. Many patients transition between oral and injectable GLP-1 medications based on side effects, preference, or availability. Your provider will guide the switch to keep your treatment on track.
Do I need to see a doctor in person first? No. Arizona allows TeleSlim providers to evaluate and prescribe entirely through video visits, as long as the visit meets the same standard of care as an in-person exam.
Ready to Get Started?
If you're in Phoenix, Scottsdale, Tempe, Mesa, or anywhere in the surrounding area and want to know whether Foundayo, injectable tirzepatide, or another GLP-1 medication is right for you, the first step is a conversation with a licensed provider. Book a free consultation with TeleSlim Clinic to get a personalized, medically accurate recommendation — no in-person visit required.
